Viking Therapeutics, Inc. (VKTX) closed the latest trading day at $23.91, indicating a -0.99% change from the previous session's end. The stock's change was less than the S&P 500's daily gain of 0.38% ...

A new genetic study revealed distinct Viking origins for the Faroe Islands and Iceland, challenging previous assumptions about the uniformity of Norse settlements in the North Atlantic.

More than 60 people from Scotland’s Northern Isles have been given personalised health insights to support their future care after receiving bespoke genetic results as part of a study into the region.

Viking Therapeutics, Inc. currently has a Zacks Rank of #3 (Hold). The Medical - Biomedical and Genetics industry is part of the Medical sector. This industry, currently bearing a Zacks Industry ...

Promises of free drugs developed from research on the Icelandic gene pool and free genetic testing for identified susceptibility alleles, as well as a boost to Icelandic science and economy have ...

Viking Therapeutics, Inc. presently features a Zacks Rank of #3 (Hold). The Medical - Biomedical and Genetics industry is part of the Medical sector. With its current Zacks Industry Rank of 65 ...